Immuron (IMRN) Net Cash Flow (2016 - 2023)
Immuron (IMRN) posted Net Cash Flow of $1317.0 for Q4 2023, down 0.87% on a QoQ basis from $1328.5 in Q4 2022, and down 0.87% year-over-year from $1328.5 in Q4 2022.
Powered by 
Analysis
Immuron (IMRN) Net Cash Flow (2016 - 2023) Analysis & Trends
Immuron has reported Net Cash Flow for 8 years, with the latest figure at $1317.0 in Q4 2023.
- On a quarterly basis, Net Cash Flow fell 0.87% year-over-year to $1317.0 in Q4 2023; TTM through Dec 2023 was $21.9 million, a 1.4% increase from a year earlier, with the FY2026 full-year figure at $6.5 million, up 173.05% from the prior year.
- Net Cash Flow was $1317.0 for Q4 2023 at Immuron, down from $1328.5 in the prior quarter.
- The five-year high for Net Cash Flow was $23.9 million in Q4 2020, with the low at -$2.0 million in Q4 2021.
- Average Net Cash Flow over 5 years is $4.3 million, with a median of $1317.0 recorded in 2023.
- The sharpest annual moves came in 2020 and 2021: Net Cash Flow surged 8005.28% in 2020, then sank 108.27% in 2021.
- Over 5 years, Net Cash Flow stood at -$302214.0 in 2019, then soared by 8005.28% to $23.9 million in 2020, then tumbled by 108.27% to -$2.0 million in 2021, then surged by 100.07% to $1328.5 in 2022, then slipped by 0.87% to $1317.0 in 2023.
- The last three Net Cash Flow figures came in at $1317.0 (Q4 2023), $1328.5 (Q4 2022), and -$2.0 million (Q4 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -4.43 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 652.90 Mn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | -504.30 Mn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | -183.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | -496,000.00 |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | -170.75 Mn |
| 10 | Immuron | 7.14 Mn | -1.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 1,316.95 |
| Dec 31, 2022 | 1,328.50 |
| Dec 31, 2021 | -1.98 Mn |
| Dec 31, 2020 | 23.89 Mn |
| Dec 31, 2019 | -302,214.00 |
| Dec 31, 2018 | -424,901.00 |
| Dec 31, 2017 | -2.64 Mn |
| Dec 31, 2016 | 3.96 Mn |
API Access
Immuron Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=IMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "IMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=IMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();